SOCIETY FOR NEUROSCIENCE for SOCIETY FOR NEUROSCIENCE
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Science/Technology SCI
Expressed positions concerning the use of fetal tissue in biomedical and basic research, specifically concerning the research of neuroscientists.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL HEINTZ | — |
Budget/Appropriations BUD
Advocacy efforts related to FY19 and FY20 funding for the National Science Foundation (NSF) and FY20 funding for the National Institutes of Health (NIH). Additional advocacy efforts include stating support for continuing brain research as a top national priority as part of overall federal investment in biomedical research and efforts related to BRAIN Initiative.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHRYN GRADY | — |
| MICHAEL HEINTZ | — |
Animals ANI
Expressed positions of support of the ethical use of animals in biomedical research at Congressional office meetings at the US Senate and US House of Representatives.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHRYN GRADY | — |
| MICHAEL HEINTZ | — |
Medical/Disease Research/Clinical Labs MED
Outreach and communication to Congress on the over 1,000 neurological and neurodegenerative diseases that affect nearly 100 million Americans.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHRYN GRADY | — |
| MICHAEL HEINTZ | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.